
Science advances at a dizzying pace, some researchers don’t just contribute to progress — they actively shape it from within the institutions they serve. One such example is Anthony Molina, PhD, Professor of Medicine at the University of California, San Diego (UCSD), and Scientific Director of the Stein Institute for Research on Aging.
Molina is more than a scientist — he is an intrapreneur: an innovator who acts like an entrepreneur from within a large organization. Instead of building a startup, he brings entrepreneurial thinking to the lab, to academic strategy, and to how research is used as a tool for meaningful societal change.
Anthony Molina’s work centers on understanding the biological processes of aging and finding ways to promote active longevity — not just a longer life, but a better one. At the Stein Institute, he leads multidisciplinary teams that combine genetics, metabolomics, epigenetics, and artificial intelligence to identify the factors that contribute to healthy aging.
He doesn’t just guide research — he also builds bridges between science, industry, and public policy. Molina collaborates with medical centers, biotech startups, and government agencies to turn lab discoveries into real-world solutions for an increasingly aging global population.
Molina’s intrapreneurial spirit is evident in how he approaches complex challenges: by spotting opportunities, reimagining existing resources, and proposing unconventional solutions within the often rigid structure of academia. For instance, he has contributed to the development of new methods for assessing “biological age” as opposed to chronological age — a breakthrough with direct applications in personalized medicine.
He is also a strong advocate for interdisciplinary collaboration and a dedicated mentor to the next generation of researchers, whom he encourages to think critically but also boldly — just like an intrapreneur.
Behind the numbers, graphs, and data, Anthony Molina always keeps the individual at the center. His goal isn’t just to understand aging but to improve it for millions of people. He’s driven by the idea that science should not only explain the world — it should help transform it.
As an intrapreneur, he’s shifting the paradigm of aging research from reactive to proactive, from treatment to prevention, from decline to quality of life.






